Altimmune ALT
NASDAQ ALT
$1.80 -0.13 (-6.48%)
As of: Nov 12, 2026 · 11:07 AM EST

Altimmune (ALT) Income Taxes Paid (2009 - 2017)

Updated

Analysis

Altimmune (ALT) Income Taxes Paid (2009 - 2017) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Taxes Paid (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -4.69 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 426.00 Mn
10 Altimmune 377.28 Mn -764.94 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2017 3.16 Mn
Mar 31, 2009 184,226.00
API Access

Altimmune Income Taxes Paid API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=income-taxes-paid&ticker=ALT&period=max&api_key=YOUR_API_KEY